Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis

NCT00116454 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

73

Enrollment

OTHER_GOV

Sponsor class

Conditions

Carcinoma, Hepatocellular
Hepatitis, Viral, Human

Interventions

DRUG: 131 I-lipiodol

Sponsor

ANRS, Emerging Infectious Diseases